ViiV HIV prevention trial stopped early on efficacy
ViiV said cabotegravir was found to be 69% more effective at preventing HIV acquisition than daily oral PrEP with emtricitabine/tenofovir disoproxil (FTC/TDF)
Read More
Tag: prevention
“Prevention more important than cure”, say MPs on NHS
49% of MPs said that they are confident that the NHS Long Term Plan will be successful in improving the prevention of ill health and disease.
Read More
Health secretary throws his weight behind social prescribing
Health secretary Matt Hancock has announced plans to establish a National Academy for Social Prescribing to lead the practice under a renewed drive to improve the prevention of ill health.
Read More
Health secretary unveils plans for greater focus on ill health prevention
Health secretary Matt Hancock is planning to breathe new life into the government’s approach to prevention of ill health, with a shift in focus to primary and community services.
Read More
Teva’s anti-CGRP drug Ajovy cleared for migraine prevention
US regulators have approved Teva’s Ajovy for the preventative treatment of migraine in adults.
Read More
Patients on diabetes scheme shed weight of 15 double cheeseburgers
According to NHS England more than half of patients routinely attending sessions offered as part of its diabetes prevention programme have achieved weight losss equivalent to nearly 15 double cheeseburgers.
Read More
ViiV trials drug for HIV prevention in women
ViiV Healthcare has initiated a Phase III study exploring the efficacy of long-acting cabotegravir for the prevention of HIV infection in sexually active women.
Read More
Further rollout for diabetes prevention programme
NHS England has announced the launch of the second wave of the Diabetes Prevention Programme, with 13 new areas now ready to offer the scheme to patients identified at risk of developing the condition.
Read More
NICE backs use of drugs for breast cancer prevention
The National Institute for Health and Care Excellence has now published updated familial breast cancer guidelines which advocate the use of three medicines to reduce the risk of developing the disease.
Read More
GPs want more support in prescribing cancer prevention drugs
GPs need better support in prescribing medicines that lower the risk of certain cancers, according to a new study by Cancer Research UK, published in the British Journal of General Practice.
Read More
NHS England to fund HIV prevention programme
NHS England has announced that it will fund a “major extension” of Public Health England’s HIV prevention programme to help reduce the incidence of the disease across the country.
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
